This hypothesis can be supported by the mediation analysis performed in this study, which indicates that adiponectin acts as a suppressor of the association between the CDH13 genotypes/haplotypes and the various metabolic phenotypes and metabolic syndrome. The gene discussed is CDH13; the disease is metabolic syndrome.